Type 1 Diabetes TrialNet Protocol TN-18 CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The goal of this study is to learn if abatacept helps delay or prevent the development of type 1 diabetes in people who have relatives with this disease.
Description
The goal of this study is to learn if abatacept helps delay or prevent the development of type 1 diabetes in people who have relatives with this disease.
Details
| Condition | Diabetes - Type I |
|---|---|
| Age | 6years - 45years |
| Clinical Study Identifier | TX3088 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.